Stay updated with breaking news from K ras. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Patients with metastatic colorectal cancer who have the KRAS G12C mutation demonstrated improved quality of life following sotorasib and panitumumab compared with standard therapy. ....
A comprehensive study exploring NSCLC subgroup responses to immunotherapy may help determine which patients are less likely to benefit from these agents. ....